Safe medications thanks to new test procedures
High-Tech Gründerfonds invests in SIGNATOPE GmbH
26-May-2017 -
High-Tech Gründerfonds(HTGF) is investing EUR 600,000 in Reutlingen-based SIGNATOPE GmbH. SIGNATOPE will use the funds to advance the development of its unique biomarker assay system, that has been established to support pharmaceutical research. The technology is based on special antibodies and ...
biomarker
drug development
investments
+1